Overview

Bioequivalence Study Of Verapamil

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate bioequivalence of single doses of two verapamil formulations
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Verapamil